These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 25559093)
1. The role of tissue factor in normal pregnancy and in the development of preeclampsia: A review. Prochazkova J; Slavik L; Ulehlova J; Prochazka M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):192-6. PubMed ID: 25559093 [TBL] [Abstract][Full Text] [Related]
2. Tissue factor and tissue factor pathway inhibitor in women with a past history of preeclampsia: implication for a hypercoagulable state postpregnancy. Lwaleed BA; Breish MO; Birch BR; Chowdhary AP; Saad RA; Perigo O; Kazmi RS; Dusse LM; Cooper AJ Blood Coagul Fibrinolysis; 2014 Oct; 25(7):671-4. PubMed ID: 24806321 [TBL] [Abstract][Full Text] [Related]
3. Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor. Godoi LC; Gomes KB; Alpoim PN; Carvalho Md; Lwaleed BA; Sant'Ana Dusse LM J Thromb Thrombolysis; 2012 Jul; 34(1):1-6. PubMed ID: 22461171 [TBL] [Abstract][Full Text] [Related]
4. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death. Erez O; Gotsch F; Mazaki-Tovi S; Vaisbuch E; Kusanovic JP; Kim CJ; Chaiworapongsa T; Hoppensteadt D; Fareed J; Than NG; Nhan-Chang CL; Yeo L; Pacora P; Mazor M; Hassan SS; Mittal P; Romero R J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615 [TBL] [Abstract][Full Text] [Related]
5. The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients. Teng Y; Jiang R; Lin Q; Ding C; Ye Z Thromb Res; 2010 Jul; 126(1):e41-5. PubMed ID: 20226500 [TBL] [Abstract][Full Text] [Related]
6. Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. Teng YC; Lin QD; Lin JH; Ding CW; Zuo Y J Perinat Med; 2009; 37(4):343-8. PubMed ID: 19290852 [TBL] [Abstract][Full Text] [Related]
7. Possibility of Coagulation System Activation Determination with Tissue Factor in Pregnancy Complications. Slavik L; Novak M; Ulehlova J; Prochazka M; Prochazkova J; Lattova V; Polak P; Pilka R Clin Lab; 2016 Oct; 62(10):1851-1856. PubMed ID: 28164533 [TBL] [Abstract][Full Text] [Related]
8. Elevated plasma TFPI activity causes attenuated TF-dependent thrombin generation in early onset preeclampsia. Egan K; O'Connor H; Kevane B; Malone F; Lennon A; Al Zadjali A; Cooley S; Monteith C; Maguire P; Szklanna PB; Allen S; McCallion N; Ní Áinle F Thromb Haemost; 2017 Jul; 117(8):1549-1557. PubMed ID: 28569919 [TBL] [Abstract][Full Text] [Related]
9. Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery. Xiong Y; Zhou SF; Zhou R; Yang D; Xu ZF; Lou YT; Guo QS; Hu R; Peng T; Ma D; Li XT Hypertens Pregnancy; 2011; 30(3):347-58. PubMed ID: 21174589 [TBL] [Abstract][Full Text] [Related]
10. Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes. Erez O; Romero R; Vaisbuch E; Than NG; Kusanovic JP; Mazaki-Tovi S; Gotsch F; Mittal P; Dong Z; Chaiworapongsa T; Kim CJ; Nhan-Chang CL; Kim SK; Yeo L; Mazor M; Hassan SS J Matern Fetal Neonatal Med; 2018 Jun; 31(12):1568-1577. PubMed ID: 28521572 [TBL] [Abstract][Full Text] [Related]
11. [Hemostatic system parameters of placental extracts in normal pregnancy and severe preeclampsia]. López-Ramírez Y; Carvajal Z; Arocha-Piñango CL Invest Clin; 2006 Sep; 47(3):233-40. PubMed ID: 17672283 [TBL] [Abstract][Full Text] [Related]
12. Changes of plasma and placental tissue factor pathway inhibitor-2 in women with preeclampsia and normal pregnancy. Xiong Y; Zhou Q; Jiang F; Zhou S; Lou Y; Guo Q; Liang W; Kong D; Ma D; Li X Thromb Res; 2010 Jun; 125(6):e317-22. PubMed ID: 20347477 [TBL] [Abstract][Full Text] [Related]
13. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Steppich B; Mattisek C; Sobczyk D; Kastrati A; Schömig A; Ott I Thromb Haemost; 2005 Jan; 93(1):35-9. PubMed ID: 15630488 [TBL] [Abstract][Full Text] [Related]
14. Tissue factor dependent pathway and the diagnosis of pre-eclampsia. Lwaleed BA; Dusse L; Cooper AJ Semin Thromb Hemost; 2011 Mar; 37(2):125-30. PubMed ID: 21370212 [TBL] [Abstract][Full Text] [Related]
15. Role of tissue factor in pregnancy complications: crosstalk between coagulation and inflammation. Girardi G Thromb Res; 2011 Feb; 127 Suppl 3():S43-6. PubMed ID: 21262438 [TBL] [Abstract][Full Text] [Related]
16. Tissue factor and tissue factor pathway inhibitor: a potential role in pregnancy and obstetric vascular complications? Dusse LM; Carvalho Md; Cooper AJ; Lwaleed BA Clin Chim Acta; 2006 Oct; 372(1-2):43-6. PubMed ID: 16713593 [TBL] [Abstract][Full Text] [Related]
18. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus. Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387 [TBL] [Abstract][Full Text] [Related]
19. Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia. Tchaikovski SN; Thomassen MC; Costa SD; Peeters LL; Rosing J Thromb Haemost; 2011 Nov; 106(5):914-21. PubMed ID: 21979881 [TBL] [Abstract][Full Text] [Related]